Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.

[1]  Bruno Sangro,et al.  Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges, and clinical perspectives , 2013, Hepatology.

[2]  See-Ching Chan.  Liver Transplantation for Hepatocellular Carcinoma , 2013, Liver Cancer.

[3]  W. Weichert,et al.  Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis , 2012, Clinical transplantation.

[4]  A. Tsung,et al.  Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease , 2012, Hepatology.

[5]  J. Zang,et al.  Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis , 2012, Journal of Cancer Research and Clinical Oncology.

[6]  Giorgio Saracco,et al.  The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study , 2011, Hepatology.

[7]  M. Abecassis,et al.  Radiologic–Pathologic Correlation of Hepatocellular Carcinoma Treated with Chemoembolization , 2010, CardioVascular and Interventional Radiology.

[8]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[9]  A. Zhu,et al.  Metabolic syndrome and hepatocellular carcinoma , 2009, Cancer.

[10]  M. Abecassis,et al.  A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  V. Mazzaferro,et al.  Liver Transplantation for Hepatocellular Carcinoma , 2008, Annals of Surgical Oncology.

[12]  H. Becker,et al.  Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation. , 2007, World journal of gastroenterology.

[13]  M. Abecassis,et al.  Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation , 2006, Journal of surgical oncology.

[14]  G. Otto,et al.  Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  R. Freeman,et al.  Waiting List Removal Rates Among Patients with Chronic and Malignant Liver Diseases , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[17]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[18]  B. Carr.  Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  T. Davern,et al.  Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention‐to‐treat principle and dropout from the waiting list , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  A. Venook,et al.  Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.

[21]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[22]  H. Bismuth,et al.  Liver Transplantation for Hepatocellular Carcinoma , 1999, Seminars in liver disease.